- Home
- HVT vs REPL Comparison
HVT vs REPL Comparison
Compare HVT & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HVT | REPL |
|---|---|---|
| Founded | 1885 | 2015 |
| Country | United States | United States |
| Employees | 2392 | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.4M | 407.1M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | HVT | REPL |
|---|---|---|
| Price | $26.34 | $9.39 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $5.67 |
| AVG Volume (30 Days) | 96.4K | ★ 3.2M |
| Earning Date | 05-05-2026 | 05-21-2026 |
| Dividend Yield | ★ 6.05% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.83 | N/A |
| Revenue Next Year | $8.70 | N/A |
| P/E Ratio | $22.08 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.53 | $1.50 |
| 52 Week High | $27.67 | $13.24 |
Technical Indicators
Market Signals| Indicator | HVT | REPL |
|---|---|---|
| Relative Strength Index (RSI) | 68.70 | 44.61 |
| Support Level | $25.52 | $8.25 |
| Resistance Level | $27.50 | $10.71 |
| Average True Range (ATR) | 0.76 | 0.83 |
| MACD | -0.01 | -0.40 |
| Stochastic Oscillator | 87.39 | 15.18 |
Price Performance
Historical ComparisonAbout HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of revenue from its upholstery products and, secondarily, from bedroom furniture.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.